Skip to main content
News > News > Jason Barkeloo, Chairman and Founder of Open Therapeutics, to speak at the next Xavier Health lunch and learn July 20, 2017

Jason Barkeloo, Chairman and Founder of Open Therapeutics, to speak at the next Xavier Health lunch and learn July 20, 2017

The Next “Big Cure” is Here and Waiting. How can your company benefit? How can you benefit?
Thursday, July 20 from 12:00 – 12:30 pm

Join industry thought leaders for our 3rd Thursday Lunch & Learns!

We Believe

Open Therapeutics crowdsources orphan and dormant therapeutic intellectual properties (IP) to scientists around the world. The goal is advancing research that ordinarily has not generated a public value or been recognized. This approach particularly helps underserved scientists to collaborate with their more financially capable colleagues.

How open science helps researchers succeed:

Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers.

The review of the literature demonstrates that open science is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open science practices bring significant benefits to researchers relative to more traditional closed practices.

Secured By miniOrange